Brain Chip of This Company Nearing FDA Approval.
Paradromics is one step closer to getting US Food and Drug Administration approval for commercial approval of its brain chip that will treat paralyzed
Source: wsnewspublishers.com
📰 Device Designation News
Page 7 - Device Designation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Device Designation. Real-time updates on events, politics, business and more.
ONWARD Reports Q1 Business Update and Year-To-Date Highlights
First-in-Human Use of the ARC-IM™ LeadNew Breakthrough Device Designation Awarded by the U.S. FDA for ARC Therapy™, Bringing Total to 9 10 Additional Patents Issued, Bringing Total Pending... | May 16, 2023
United States University Of Miami Erika Ross Ellison Abbott Neuromodulation Lara Smith Weber Aditi Roy
Source: marketscreener.com
ONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury
New lead is purpose-designed to optimize the delivery of ONWARD ARC Therapy™EINDHOVEN, the Netherlands, May 15, 2023 -- ONWARD Medical N.V. , the medical technology company creating... | May 15, 2023
United States Aditi Roy Lara Smith Weber Lausanne University Hospital University Of Calgary Company Enquiries
Source: marketscreener.com
ONWARD Medical: ONWARD Announces First-in-Human Use of ARC-IM Lead to Restore Movement and Function after Spinal Cord Injury
New lead is purpose-designed to optimize the delivery of ONWARD ARC TherapyEINDHOVEN, the Netherlands, May 15, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company
United States Aditi Roy Lara Smith Weber Company Enquiries Centre Hospitalier Universitaire Vaudois Swiss Federal Institute Of Technology
Source: finanznachrichten.de
Ultromics Granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis Detection
The platform uses artificial intelligence to analyze echocardiograms and detect the presence of cardiac amyloidosis
Najat Khan Ross Upton Janssen Pharmaceutical Companies Of Johnson Janssen Biotech Inc Strategy Operations At Janssen Research Development Device Status
Source: dicardiology.com
Promis Diagnostics' EarlyTect BCD Receives FDA Breakthrough Device Designation for Bladder Cancer Detection
/PRNewswire/ -- Promis Diagnostics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to...
United States Justin Lee Prnewswire Promis Diagnostics Inc Drug Administration Clinical Laboratory Improvement Amendments College Of American Pathologists
Source: prnewswire.com
Global Multicancer Screening Market to Reach $7.78 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS Research
/PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Multicancer...
United States Akash Mhaskar Thermo Fisher Scientific Inc Illumina Inc Invitae Corporation Technologies Inc
Source: prnewswire.com
Global Multicancer Screening Market to Reach $7.78 Billion by 2032 - Exclusive DeepTech M-A-P Analysis by BIS Research
New discoveries of specific biomarkers related to various cancer types are increasing researchers' trust in multicancer sequencing. FREMONT, Calif., April 28, 2023 /PRNewswire/ -- BIS Research
United States Akash Mhaskar Sciences Corporation Illumina Inc Guardant Health Inc Genecast Biotechnology Co Ltd
Source: finanznachrichten.de
Ultromics receives Breakthrough Device Designation for AI cardiac amyloidosis tool and more digital health briefs
Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.
Source: mobihealthnews.com
CytoSorbents' Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
PRINCETON, N.J., April 20, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via... | April 20, 2023
United States Kathleen Bloch Efthymiosn Deliargyris National Institutes Of Health Health Canada Blood Institute
Source: marketscreener.com